MINI FUTURE SHORT ZERTIFIKAT MIT SL - UCB

MINI FUTURE SHORT ZERTIFIKAT MIT SL - UCB Share Price

DE000NG8UJN1

Market Closed - Boerse Frankfurt Warrants 15:47:34 01/07/2024 BST
5.1 ^EUR	-5.38%

Current month	-5.38%
1 month	-21.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Chart MINI FUTURE SHORT ZERTIFIKAT MIT SL - UCB

Latest news about UCB

UCB : spotlights new analyses and patient insights supporting its recently launched gMG portfolio at the 10th Congress of the European Academy of Neurology (EAN)	06-28	PU
UCB : Financial Reporting Document	06-26	PU
UCB : Financial Reporting Document	06-26	PU
UCB : epilepsy drug BRIVIACT(brivaracetam) approved in Japan for treatment of focal onset seizures	06-26	PU

More news

Quotes 5-day view

Date	Price	Change
01/07/24	5.1	-5.38%
28/06/24	5.39	-1.64%
27/06/24	5.48	-2.32%
26/06/24	5.61	+2.37%
25/06/24	5.48	+0.92%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 03:47 pm

More quotes

Static data

Product type	Certificat Turbo Stop Loss
Buy / Sell	PUT
Underlying	UCB
Issuer	ING Bank
WKN	NG8UJN
ISIN	DE000NG8UJN1
Date issued	31/05/2024
Strike	192.1 €
Maturity	Unlimited
Parity	10 : 1
Emission price	6 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	6.54 €
Lowest since issue	5.04 €

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

140.2 EUR

Average target price

139.7 EUR

Spread / Average Target

-0.39%

Consensus